Actively Recruiting
Intracranial PrEssure Time dOse (ImPETO)
Led by University of Milano Bicocca · Updated on 2025-09-15
250
Participants Needed
1
Research Sites
163 weeks
Total Duration
On this page
Sponsors
U
University of Milano Bicocca
Lead Sponsor
I
Integra LifeSciences Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The new Integra CereLink ICP monitor integrate the possibility of recording and displaying continuously the AUC (Pressure Time Dose, PTD) and other ICP derived variables and provide the possibility of evaluating the utility of this information at the bedside. It offers the opportunity to test in a standardized way the clinical value of the PTD computation in this setting. Therefore, this study aims to test clinically if PTD recorded continuously is associated to patients' outcome and to identify a threshold of PTD associated with the transition from good to negative outcomes.
CONDITIONS
Official Title
Intracranial PrEssure Time dOse (ImPETO)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged within 18 and 80 years
- Diagnosed with an acute brain injury (ABI) including hemorrhagic stroke (intracerebral hematoma or subarachnoid hemorrhage) or traumatic brain injury
- ICP monitoring started for clinical indication according to local policies
- ICP device connected to the Integra CereLink ICP monitor
You will not qualify if you...
- ICP monitoring not inserted
- No availability of the Integra CereLink ICP monitor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy, 20900
Actively Recruiting
Research Team
G
Giuseppe Citerio, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here